Medicine

siRNA therapy lowers triglycerides in patients with uncommon health condition

.RESEARCH STUDY HIGHLIGHT.19 September 2024.

Plozasiran reduced triglyceride amounts by 80% and also reduced the danger of pancreatitis in people with persistent chylomicronemia, along with or even without a genetic medical diagnosis.

Articles You Can Be Interested In